CLASS II Drug recall · Reported 25 Nov 2020 · FDA Enforcement Report
DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid) recalled
Milbar Laboratories is recalling DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid)/, Dermatologic Cosmetic, distributed nationwide in the US. The recall was initiated on 9 Oct 2020 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0095-2021
- FDA event ID
- 86579
- Recalling firm
- Milbar Laboratories, East Haven, CT
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 9 Oct 2020
- FDA classified
- 17 Nov 2020
- Reported
- 25 Nov 2020
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Processing Deviation
- Drug class
- Sunscreen & Personal Care
Timeline
| 9 Oct 2020 | Recall initiated by company | |
| 17 Nov 2020 | Classified by FDA | +39 days |
| 25 Nov 2020 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
GMP Deviations
The USDA issues these when meat or poultry was produced without proper inspection, or when a step such as cooking or pasteurisation did not meet requirements.
Product as listed by the FDA
DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid), 50ml/1.7 fl. oz, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA
Where it was distributed
Product was distributed throughout the United States, including Puerto Rico and internationally.
Questions about this recall
Why was it recalled?
GMP Deviations
Which lots are affected?
Lot #: FX432-5, Exp. Date June-21
Where was it sold?
Product was distributed throughout the United States, including Puerto Rico and internationally.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
13 other products · FDA event 86579This product is part of a recall event; the main page for the event is DCL B Prox10 Anti-Blemish Wash recalled by Milbar Laboratories.
More recalls from Milbar Laboratories
All 20| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | (Malin+Goetz) spf 30 face moisturizer (Avobenzone recalled | Milbar Laboratories | Processing Deviation | Nationwide |
| Drug | CLASS II | (Malin + Goetz) Salicylic Gel (2% Salicylic Acid) tube recalled | Milbar Laboratories | Processing Deviation | Nationwide |
| Drug | CLASS II | DCL SA Scalp Therapy Shampoo recalled by Milbar Laboratories | Milbar Laboratories | Processing Deviation | Nationwide |
| Drug | CLASS II | DCL Active Mattifying Cleanser recalled by Milbar Laboratories | Milbar Laboratories | Processing Deviation | Nationwide |
| Drug | CLASS II | MD Complete Breakout Treatment (Benzoyl Peroxide 4.5%) recalled | Milbar Laboratories | Processing Deviation | Nationwide |